D. Law

发表

Virulence factors of enteropathogenic Escherichia coli.

D. Law, 1988, Journal of medical microbiology.

In Vivo Efficacy of Olorofim against Systemic Scedosporiosis and Lomentosporiosis

S. Seyedmousavi, J. Rex, K. Kwon-Chung, 2021, Antimicrobial agents and chemotherapy.

The influence of salt concentration on the detection of methicillin resistance in coagulase-negative staphylococci.

D. Law, G. Megson, M. Keaney, 1992, The Journal of antimicrobial chemotherapy.

The history and evolution of Escherichia coli O157 and other Shiga toxin-producing E. coli

D. Law, 2000 .

Diagnosis of infections with Shiga-like toxin-producing Escherichia coli by use of enzyme-linked immunosorbent assays for Shiga-like toxins on cultured stool samples.

D. Denning, D. Acheson, D. Law, 1994, Journal of medical microbiology.

Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease

R. Kolamunnage-Dona, J. Rex, W. Hope, 2017, mBio.

Adhesion and its role in the virulence of enteropathogenic Escherichia coli

D. Law, Derek Law, 1994, Clinical Microbiology Reviews.

Variation in morphotype, karyotype and DNA type of fluconazole resistant Candida albicans from an AIDS patient.

D. Denning, M. Anderson, D. Law, 1998, The Journal of infection.

The iron uptake mechanisms of enteropathogenic Escherichia coli: the use of haem and haemoglobin during growth in an iron-limited environment.

D. Law, F. Gould, R. Freeman, 1992, Journal of medical microbiology.

Examination of enteropathogenic Escherichia coli strains for an adenylcyclase stimulating factor.

D. Law, R. Freeman, K. M. Wilkie, 1987, Journal of medical microbiology.

Rapid genotyping ofEscherichia coli O157 isolates by random amplification of polymorphic DNA

D. Denning, D. Law, M. Birch, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2.

D. Acheson, B. Rowe, H. Chart, 1993, Journal of clinical pathology.

Detection of verotoxin-producing strains of Escherichia coli.

D. Law, 1993, The Journal of infection.

Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance

W. Melchers, J. Zoll, P. Verweij, 2021, bioRxiv.

Effect of the Novel Antifungal Drug F901318 (Olorofim) on Growth and Viability of Aspergillus fumigatus

N. Read, A. Brand, D. Law, 2018, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents

E. Berkow, S. Lockhart, Natalie S. Nunnally, 2021, Journal of fungi.

In vitro activity of the novel antifungal compound F901318 against difficult‐to‐treat Aspergillus isolates

W. Melchers, J. Meis, P. Verweij, 2017, The Journal of antimicrobial chemotherapy.

Efficacy of Olorofim (F901318) against Aspergillus fumigatus, A. nidulans, and A. tanneri in Murine Models of Profound Neutropenia and Chronic Granulomatous Disease

S. Seyedmousavi, J. Rex, K. Kwon-Chung, 2019, Antimicrobial Agents and Chemotherapy.

High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

D. Denning, C. Moore, D. Law, 1994, The Journal of antimicrobial chemotherapy.

In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi.

T. Sorrell, J. Rex, D. Law, 2018, Medical mycology.

Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei

P. Warn, C. Lass‐Flörl, U. Binder, 2018, The Journal of antimicrobial chemotherapy.

Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans

N. Wiederhold, D. Law, M. Birch, 2017, The Journal of antimicrobial chemotherapy.

Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatus

G. Robson, D. Denning, D. Law, 1996, Infection and immunity.

Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards

D. Denning, C. Moore, D. Law, 1994, Antimicrobial Agents and Chemotherapy.

Amphotericin B resistance testing of Candida spp.: a comparison of methods.

D. Denning, C. Moore, D. Law, 1997, The Journal of antimicrobial chemotherapy.

In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp.

D. Denning, C. Moore, D. Law, 1993, The Journal of antimicrobial chemotherapy.

Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp

D. Denning, C. Moore, D. Law, 1997, Antimicrobial agents and chemotherapy.

In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificans

E. Berkow, S. Lockhart, Natalie S. Nunnally, 2023, Microbiology spectrum.

F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase

M. Slater, M. Bromley, N. Wiederhold, 2016, Proceedings of the National Academy of Sciences.

The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis

J. Rex, G. Catano, T. Patterson, 2018, Antimicrobial Agents and Chemotherapy.

In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp

D. Denning, C. Moore, D. Law, 1995, Antimicrobial agents and chemotherapy.

Discrepancies associated with the measurement of itraconazole serum concentrations by bioassays.

D. Denning, C. Moore, D. Law, 1999, The Journal of antimicrobial chemotherapy.

Characterization of Aspergillus isolates by pyrolysis mass spectrometry

R. Freeman, P. Sisson, D. Denning, 1996, Mycoses.

Virulence factors of Escherichia coli O157 and other Shiga toxin‐producing E. coli

D. Law, 2000, Journal of applied microbiology.

Use of heme and hemoglobin by Escherichia coli O157 and other Shiga-like-toxin-producing E. coli serogroups

D. Law, J. Kelly, Derek Law, 1995, Infection and immunity.

Detection by ELISA of low numbers of Shiga-like toxin-producing Escherichia coli in mixed cultures after growth in the presence of mitomycin C.

L A Ganguli, D. Acheson, D. Law, 1992, Journal of medical microbiology.

Exa m i n at i o n of e n t e ro pa t h og e n i c Escherichia co/i strains for an adenylcyclase stimulating factor

D. Law, R. Freeman, K. M. Wilkie, 1987 .

ASSESSMENT OF POTENTIAL SARS-CoV-2 VIRUS N GENE INTEGRATION INTO HUMAN GENOME REVEALS NO SIGNIFICANT IMPACT ON RT-qPCR COVID-19 DIAGNOSTIC TESTING

E. Briggs, N. Ostrov, P. Mita, 2021, medRxiv.

The Dynamic Influence of Olorofim (F901318) on the Cell Morphology and Organization of Living Cells of Aspergillus fumigatus

N. Read, M. Bromley, D. Law, 2020, Journal of fungi.

Problems of thermonuclease detection for identifying Staphylococcus aureus in blood culture broths.

D. Law, G. Megson, L. Ganguli, 1991, Journal of clinical pathology.

High incidence of antifungal drug resistance in Candida tropicalis.

C B Moore, M G Keaney, D. Denning, 1996, International journal of antimicrobial agents.

In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida spp

D. Denning, D. Law, H. Wardle, 1996, Antimicrobial agents and chemotherapy.